Paper40947735
Investigating the Mechanism of Astragalus mongholicus-Mediated Treatment of Silicosis in Mice from the Perspective of Alternative Splicing.
Zhang Y and 3 others. Curr Drug Targets, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Investigating the Mechanism of Astragalus mongholicus-Mediated Treatment of Silicosis in Mice from the Perspective of Alternative Splicing. Papers, record 40947735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40947735
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Investigating the Mechanism of Astragalus mongholicus-Mediated Treatment of Silicosis in Mice from the Perspective of Alternative Splicing.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Silicosis | Major topic |
| Alternative Splicing | Major topic |
| Astragalus Plant | Major topic |
| Drugs, Chinese Herbal | Major topic |
| Animals | |
| Mice | |
| Molecular Docking Simulation | |
| Disease Models, Animal | |
| Lung | |
| Protein Serine-Threonine Kinases | |
| Male |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 62371265, 62161039 | National Natural Science Foundation of China | PubMed | ||
| 2024JQ10, 2024MS03054 | Natural Science Foundation of Inner Mongolia | PubMed | ||
| 2023RCTD023, 2023XKJX014 | Basic scientific research funding for universities directly under Inner Mongolia Autonomous Region | PubMed | ||
| 2025KYPT0135 | 2025 Inner Mongolia Key Laboratory of Life Health and Bioinformatics Project | PubMed |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33153689 | Silicosis: An Update and Guide for Clinicians. | Clin Chest Med | 2020 | https://conductscience.org/library/papers/33153689 | PubMed |
| 2 | 37349198 | Silicosis and tuberculosis: A systematic review and meta-analysis. | Pulmonology | 2025 | https://conductscience.org/library/papers/37349198 | PubMed |
| 3 | 33466366 | Macrophage Autophagy and Silicosis: Current Perspective and Latest Insights. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33466366 | PubMed |
| 4 | 35889616 | Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/35889616 | PubMed |
| 5 | 39107113 | Artificial stone silicosis: a UK case series. | Thorax | 2024 | https://conductscience.org/library/papers/39107113 | PubMed |
| 6 | 36494831 | The emerging role of epigenetic regulation in the progression of silicosis. | Clin Epigenetics | 2022 | https://conductscience.org/library/papers/36494831 | PubMed |
| 7 | 37882943 | Current and Future Treatment Landscape for Idiopathic Pulmonary Fibrosis. | Drugs | 2023 | https://conductscience.org/library/papers/37882943 | PubMed |
| 8 | 31953962 | Inflammatory and oxidative stress biomarkers induced by silica exposure in crystal craftsmen. | Am J Ind Med | 2020 | https://conductscience.org/library/papers/31953962 | PubMed |
| 9 | 35773269 | Targeting fibrosis, mechanisms and cilinical trials. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/35773269 | PubMed |
| 10 | 38712374 | Vaccine for Targeted Therapy of Lung Cancer: Advances and Developments. | Curr Drug Targets | 2024 | https://conductscience.org/library/papers/38712374 | PubMed |
| 11 | 38678001 | [Research progress of macrophage polarization in silicosis fibrosis]. | Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi | 2024 | https://conductscience.org/library/papers/38678001 | PubMed |
| 12 | 40087606 | Evaluation of respiratory muscle dysfunction in patients with idiopathic pulmonary fibrosis: a prospective observational study with magnetic resonance imaging. | BMC Pulm Med | 2025 | https://conductscience.org/library/papers/40087606 | PubMed |
| 13 | 38985878 | Pulmonary osteoclast-like cells in silica induced pulmonary fibrosis. | Sci Adv | 2024 | https://conductscience.org/library/papers/38985878 | PubMed |
| 14 | 34360876 | The Mechanism and Effect of Autophagy, Apoptosis, and Pyroptosis on the Progression of Silicosis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360876 | PubMed |
| 15 | 39944632 | Silicosis: from pathogenesis to therapeutics. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/39944632 | PubMed |
| 16 | 40051360 | Fibroblast Growth Factors: Roles and Emerging Therapeutic Applications. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/40051360 | PubMed |
| 17 | 40083511 | Burden of silicosis based on the Global Burden of Disease Study 2021: trend analysis of incidence, mortality, and disability-adjusted life years, and projections for the next 30 years. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/40083511 | PubMed |
| 18 | 37461046 | Global incidence, prevalence and disease burden of silicosis: 30 years' overview and forecasted trends. | BMC Public Health | 2023 | https://conductscience.org/library/papers/37461046 | PubMed |
| 19 | 38729953 | Research progress on morphology and mechanism of programmed cell death. | Cell Death Dis | 2024 | https://conductscience.org/library/papers/38729953 | PubMed |
| 20 | 34316030 | Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A. | Acta Pharmacol Sin | 2022 | https://conductscience.org/library/papers/34316030 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40947735
GET https://conductscience.org/api/papers/v1/40947735/references?page=2